Floatz logo

METAMIZOLE

Colorectal Cancer

Local Health Unit Barcelos/Esposende, Public Health UnitSmall moleculePhase 4 / ApprovedActive
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
59/ 100

Competitive context

481 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
UNICANCER
Phase 4BB
PANITUMUMAB
MSPU des 3 Provinces
Phase 3BB
Calcium folinate pentahydrate
UNICANCER
Phase 4BB
Levoleucovorin
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BB
Eloxatin
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

METAMIZOLE is also rated in:

post-operative pain, non-human animalDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →
Pain ManagementDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →